Founded December 2019
Stage Technology development
Investor Trendlines Incubators Israel and Bayer Trendlines Ag Innovation Fund
CEO Dotan Peleg
ProJini Agchem is developing novel agchem solutions based on new types of molecular targets: protein-protein interactions. While such interactions are at the core of any organism, it is very challenging to develop inhibitors for such systems via conventional approaches due to their spatial and chemical characteristics. The platform leverages a combination of computational-biophysical methods to confront this significant challenge. ProJini Agchem received an exclusive license to use this platform to develop novel pesticides with new modes of action.
2019: received exclusive license from MIGAL Galilee Research Institute
Over 20 years of experience as CEO with M&A record, a passionate entrepreneur with a focus on market vision, technological innovation, complete product life cycle.
Dotan holds a B.S.c in Physics from Tel Aviv University.
I5 years’ experience in research at MIGAL Galilee Research Institute and Bar-Ilan University Faculty of Medicine; PhD University of Haifa; MSc Faculty of Agriculture, HUJI – breeding & genetics; PhD Faculty of Life Science, Haifa University – drug discovery lab, fungi-based active substances; Bar Ilan Faculty of Medicine, lab manager, cancer research; Post Doctorate fellow and lab & projects manager, MIGAL Galilee Research Institute, drug discovery group;
15 years’ experience in project management and platform development for biotechnology and pharmaceutical companies. Leading R&D projects from idea to realization including budget planning, business development and directing scientific collaborations; Principal Investigator at the department of Biotechnology, MIGAL Galilee Research Institute, heading the drug discovery and computational chemistry group; MSc. Weizmann Institute of Science, chemistry and structural biology; BSc, Bar-Ilan University, biophysics;
Biophysicist, experienced in drug discovery from hit-to-lead including fragment-based drug screening and optimization, protein expression, purification and chemical optimization; Principal Investigator, Tel-Aviv University Faculty of Medicine; Group Leader, MIGAL Galilee Research Institute, drug discovery and protein interactions group; Postdoctoral studies, Harvard Medical School, proteins NMR; PhD, Weizmann Institute of Science, NMR methods development; BSc, Bar-Ilan University, biophysics;
According to FAO ,the pesticide market in 2018 reached an estimated US$55B in annual sales. Pesticides are the main tools farmers use to control pests. Pests (insects, diseases and weeds) cause up to 40% yield loss in agriculture. Current solutions are insufficient, due to increased resistance, as well as regulatory pressure.